Stroke RSS

Filtered By:
Source: ScienceDaily Headlines
Drug: Angiomax

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 1 results found since Jan 2013.

No difference in rate of adverse cardiovascular events when comparing anticoagulants
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study.
Source: ScienceDaily Headlines - May 17, 2017 Category: Science Source Type: news